Theranica, a prescribed digital therapeutics company developing advanced electroceuticals for migraine and other pain conditions, has announced that its FDA-approved acute migraine treatment wearable Nerivio has been named a silver winner of the 2021 Medical Design Excellence Awards (MDEA) in the Digital Health Products and Mobile Medical Apps category.
Follow Israel Hayom on Facebook and Twitter
Nerivio, is a the first smartphone-controlled migraine treatment device that utilizes Remote Electrical Neuromodulation (REN) to treat migraine pain. Worn on the upper arm for 45 minutes, the device stimulates the brain's innate pain regulation mechanism to alleviate migraine pain and symptoms. The treatment is personalized through the Nerivio app (available for iPhone and Android), which includes an interactive migraine diary that can be easily shared between patient and doctor to improve migraine management.
"We are honored to be recognized by the Medical Design Excellence Awards for the advanced technology behind Nerivio. The unique design and usability of the device makes it an effective treatment option and we are committed to continuing to provide patients with accessible pain relief," said Ronen Jashek, co-founder and COO of Theranica.
"Nerivio is advancing the migraine treatment market by expanding the options beyond medication – a long awaited shift in the field. Thank you to the jurors for recognizing this important alternative first-line treatment that helps patients manage this debilitating and pervasive condition."
